Global Pruritus Therapeutics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.

In this report, we study the drugs for pruritus.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Pruritus Therapeutics market is projected to reach US$ 18060 million by 2028 from an estimated US$ 14270 million in 2022, at a CAGR of 4.0% during 2023 and 2028.

Market competition is intense. J&J, Abbott, Amgen and LEO Pharma, etc. are the leaders of the industry, with about 60% market shares.

North America is the largest consumption place, with a revenue market share nearly 43%. Following North America, Europe is the second largest consumption place with the revenue market share of 27%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pruritus Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Pruritus Therapeutics.

The Pruritus Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Pruritus Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pruritus Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

J&J

Abbott

Amgen

LEO Pharma

Novartis

Bayer

Pfizer

UCB Pharma

GlaxoSmithKline

Galderma

Huapont

Product Type Insights

Global markets are presented by Pruritus Therapeutics type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Pruritus Therapeutics are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Antihistamines

Corticosteroids

Calcineurin Inhibitors

Others

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Pruritus Therapeutics market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Pruritus Therapeutics market.

External Use

Oral

Injection

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia-Pacific

China

Japan

South Korea

India

Southeast Asia

Australia

Rest of Asia-Pacific

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Pruritus Therapeutics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pruritus Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Pruritus Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Pruritus Therapeutics industry.

This report helps stakeholders to gain insights into which regions to target globally.

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pruritus Therapeutics.

1.1 Pruritus Therapeutics Product Introduction

1.2 Market by Type

1.2.1 Global Pruritus Therapeutics Market Size Growth Rate by Type (2017 VS 2021 VS 2028)

1.2.2 Antihistamines

1.2.3 Corticosteroids

1.2.4 Calcineurin Inhibitors

1.2.5 Others

1.3 Market by Application

1.3.1 Global Pruritus Therapeutics Market Size Growth Rate by Application (2017 VS 2021 VS 2028)

1.3.2 External Use

1.3.3 Oral

1.3.4 Injection

1.4 Study Objectives

1.5 Years Considered

2.1 Global Pruritus Therapeutics Market Size Estimates and Forecasts

2.2 Pruritus Therapeutics Market Size by Region: 2022 Versus 2028

2.2.1 Global Pruritus Therapeutics Revenue by Region: 2017-2022

2.2.2 Global Pruritus Therapeutics Revenue Forecast by Region (2023-2028)

2.2.3 Global Pruritus Therapeutics Revenue Market Share by Region (2017-2028)

3.1 Global Pruritus Therapeutics Revenue by Company (2017-2022)

3.2 Global Pruritus Therapeutics Revenue Share by Company (2017-2022)

3.3 Competitive Landscape

3.3.1 Key Pruritus Therapeutics Companies around the World: Ranking by Revenue

3.3.2 Global Pruritus Therapeutics Market Concentration Ratio (CR5 and HHI) & (2017-2022)

3.3.3 Global Pruritus Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.4 Global Pruritus Therapeutics Companies Headquarters & Product Type

3.4.1 Pruritus Therapeutics Companies Headquarters

3.4.2 Global Pruritus Therapeutics Companies Product & Service

3.4.3 Date of International Companies Enter into Pruritus Therapeutics Market

3.5 Global Pruritus Therapeutics Mergers & Acquisitions, Expansion Plans

4.1 J&J

4.1.1 J&J Corporation Information

4.1.2 J&J Description, Business Overview

4.1.3 J&J Pruritus Therapeutics Products Offered

4.1.4 J&J Pruritus Therapeutics Revenue and Gross Margin (2017-2022)

4.1.5 J&J Pruritus Therapeutics Revenue by Product in 2021

4.1.6 J&J Pruritus Therapeutics Revenue by Application in 2021

4.1.7 J&J Pruritus Therapeutics Revenue by Geographic Area in 2021

4.1.8 J&J Recent Developments

4.2 Abbott

4.2.1 Abbott Corporation Information

4.2.2 Abbott Description, Business Overview

4.2.3 Abbott Pruritus Therapeutics Products Offered

4.2.4 Abbott Pruritus Therapeutics Revenue and Gross Margin (2017-2022)

4.2.5 Abbott Pruritus Therapeutics Revenue by Product in 2021

4.2.6 Abbott Pruritus Therapeutics Revenue by Application in 2021

4.2.7 Abbott Pruritus Therapeutics Revenue by Geographic Area in 2021

4.2.8 Abbott Recent Developments

4.3 Amgen

4.3.1 Amgen Corporation Information

4.3.2 Amgen Description, Business Overview

4.3.3 Amgen Pruritus Therapeutics Products Offered

4.3.4 Amgen Pruritus Therapeutics Revenue and Gross Margin (2017-2022)

4.3.5 Amgen Pruritus Therapeutics Revenue by Product in 2021

4.3.6 Amgen Pruritus Therapeutics Revenue by Application in 2021

4.3.7 Amgen Pruritus Therapeutics Revenue by Geographic Area in 2021

4.3.8 Amgen Recent Developments

4.4 LEO Pharma

4.4.1 LEO Pharma Corporation Information

4.4.2 LEO Pharma Description, Business Overview

4.4.3 LEO Pharma Pruritus Therapeutics Products Offered

4.4.4 LEO Pharma Pruritus Therapeutics Revenue and Gross Margin (2017-2022)

4.4.5 LEO Pharma Pruritus Therapeutics Revenue by Product in 2021

4.4.6 LEO Pharma Pruritus Therapeutics Revenue by Application in 2021

4.4.7 LEO Pharma Pruritus Therapeutics Revenue by Geographic Area in 2021

4.4.8 LEO Pharma Recent Developments

4.5 Novartis

4.5.1 Novartis Corporation Information

4.5.2 Novartis Description, Business Overview

4.5.3 Novartis Pruritus Therapeutics Products Offered

4.5.4 Novartis Pruritus Therapeutics Revenue and Gross Margin (2017-2022)

4.5.5 Novartis Pruritus Therapeutics Revenue by Product in 2021

4.5.6 Novartis Pruritus Therapeutics Revenue by Application in 2021

4.5.7 Novartis Pruritus Therapeutics Revenue by Geographic Area in 2021

4.5.8 Novartis Recent Developments

4.6 Bayer

4.6.1 Bayer Corporation Information

4.6.2 Bayer Description, Business Overview

4.6.3 Bayer Pruritus Therapeutics Products Offered

4.6.4 Bayer Pruritus Therapeutics Revenue and Gross Margin (2017-2022)

4.6.5 Bayer Pruritus Therapeutics Revenue by Product in 2021

4.6.6 Bayer Pruritus Therapeutics Revenue by Application in 2021

4.6.7 Bayer Pruritus Therapeutics Revenue by Geographic Area in 2021

4.6.8 Bayer Recent Development

4.7 Pfizer

4.7.1 Pfizer Corporation Information

4.7.2 Pfizer Description, Business Overview

4.7.3 Pfizer Pruritus Therapeutics Products Offered

4.7.4 Pfizer Pruritus Therapeutics Revenue and Gross Margin (2017-2022)

4.7.5 Pfizer Pruritus Therapeutics Revenue by Product in 2021

4.7.6 Pfizer Pruritus Therapeutics Revenue by Application in 2021

4.7.7 Pfizer Pruritus Therapeutics Revenue by Geographic Area in 2021

4.7.8 Pfizer Recent Development

4.8 UCB Pharma

4.8.1 UCB Pharma Corporation Information

4.8.2 UCB Pharma Description, Business Overview

4.8.3 UCB Pharma Pruritus Therapeutics Products Offered

4.8.4 UCB Pharma Pruritus Therapeutics Revenue and Gross Margin (2017-2022)

4.8.5 UCB Pharma Pruritus Therapeutics Revenue by Product in 2021

4.8.6 UCB Pharma Pruritus Therapeutics Revenue by Application in 2021

4.8.7 UCB Pharma Pruritus Therapeutics Revenue by Geographic Area in 2021

4.8.8 UCB Pharma Recent Development

4.9 GlaxoSmithKline

4.9.1 GlaxoSmithKline Corporation Information

4.9.2 GlaxoSmithKline Description, Business Overview

4.9.3 GlaxoSmithKline Pruritus Therapeutics Products Offered

4.9.4 GlaxoSmithKline Pruritus Therapeutics Revenue and Gross Margin (2017-2022)

4.9.5 GlaxoSmithKline Pruritus Therapeutics Revenue by Product in 2021

4.9.6 GlaxoSmithKline Pruritus Therapeutics Revenue by Application in 2021

4.9.7 GlaxoSmithKline Pruritus Therapeutics Revenue by Geographic Area in 2021

4.9.8 GlaxoSmithKline Recent Development

4.10 Galderma

4.10.1 Galderma Corporation Information

4.10.2 Galderma Description, Business Overview

4.10.3 Galderma Pruritus Therapeutics Products Offered

4.10.4 Galderma Pruritus Therapeutics Revenue and Gross Margin (2017-2022)

4.10.5 Galderma Pruritus Therapeutics Revenue by Product in 2021

4.10.6 Galderma Pruritus Therapeutics Revenue by Application in 2021

4.10.7 Galderma Pruritus Therapeutics Revenue by Geographic Area in 2021

4.10.8 Galderma Recent Development

4.11 Huapont

4.11.1 Huapont Corporation Information

4.11.2 Huapont Description, Business Overview

4.11.3 Huapont Pruritus Therapeutics Products Offered

4.11.4 Huapont Pruritus Therapeutics Revenue and Gross Margin (2017-2022)

4.11.5 Huapont Pruritus Therapeutics Revenue by Product in 2021

4.11.6 Huapont Pruritus Therapeutics Revenue by Application in 2021

4.11.7 Huapont Pruritus Therapeutics Revenue by Geographic Area in 2021

4.11.8 Huapont Recent Development

5.1 Global Pruritus Therapeutics Revenue by Type (2017-2022)

5.2 Global Pruritus Therapeutics Revenue Forecast by Type (2023-2028)

5.3 Pruritus Therapeutics Revenue Marke Share by Type (2017-2028)

6.1 Global Pruritus Therapeutics Revenue by Application (2017-2022)

6.2 Global Pruritus Therapeutics Revenue Forecast by Application (2023-2028)

6.3 Pruritus Therapeutics Revenue Market Share by Application (2017-2028)

7.1 North America Pruritus Therapeutics Market Size YoY Growth 2017-2028

7.2 North America Pruritus Therapeutics Market Facts & Figures by Country (2017-2028)

7.3 North America Pruritus Therapeutics Revenue by Type (2017-2022)

7.4 North America Pruritus Therapeutics Revenue by Application (2017-2022)

8.1 Asia-Pacific Pruritus Therapeutics Market Size YoY Growth 2017-2028

8.2 Asia-Pacific Pruritus Therapeutics Market Facts & Figures by Region (2017-2028)

8.3 Asia-Pacific Pruritus Therapeutics Revenue by Type (2017-2022)

8.4 Asia-Pacific Pruritus Therapeutics Revenue by Application (2017-2022)

9.1 Europe Pruritus Therapeutics Market Size YoY Growth 2017-2028

9.2 Europe Pruritus Therapeutics Market Facts & Figures by Country (2017-2028)

9.3 Europe Pruritus Therapeutics Revenue by Type (2017-2022)

9.4 Europe Pruritus Therapeutics Revenue by Application (2017-2022)

10.1 Latin America Pruritus Therapeutics Market Size YoY Growth 2017-2028

10.2 Latin America Pruritus Therapeutics Market Facts & Figures by Country (2017-2028)

10.3 Latin America Pruritus Therapeutics Revenue by Type (2017-2022)

10.4 Latin America Pruritus Therapeutics Revenue by Application (2017-2022)

11.1 Middle East and Africa Pruritus Therapeutics Market Size YoY Growth 2017-2028

11.2 Middle East and Africa Pruritus Therapeutics Market Facts & Figures by Country (2017-2028)

11.3 Middle East and Africa Pruritus Therapeutics Revenue by Type (2017-2022)

11.4 Middle East and Africa Pruritus Therapeutics Revenue by Application (2017-2022)

12.1 Pruritus Therapeutics Supply Chain Analysis

12.2 Pruritus Therapeutics Key Raw Materials and Upstream Suppliers

12.3 Pruritus Therapeutics Clients Analysis

12.4 Pruritus Therapeutics Sales Channel and Sales Model Analysis

12.4.1 Pruritus Therapeutics Distribution Channel Analysis: Indirect Sales VS Direct Sales

12.4.2 Pruritus Therapeutics Distribution Channel Analysis: Online Sales VS Offline Sales

12.4.3 Pruritus Therapeutics Distributors

13.1 Pruritus Therapeutics Industry Trends

13.2 Pruritus Therapeutics Market Drivers

13.3 Pruritus Therapeutics Market Challenges

13.4 Pruritus Therapeutics Market Restraints

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

List of Tables

    Table 1. Global Pruritus Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028

    Table 2. Major Companies of Antihistamines

    Table 3. Major Companies of Corticosteroids

    Table 4. Major Companies of Calcineurin Inhibitors

    Table 5. Major Companies of Others

    Table 6. Global Pruritus Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028

    Table 7. Global Pruritus Therapeutics Market Size by Region (US$ Million): 2022 VS 2028

    Table 8. Global Pruritus Therapeutics Revenue by Region (2017-2022) & (US$ Million)

    Table 9. Global Pruritus Therapeutics Revenue Forecast by Region (2023-2028) & (US$ Million)

    Table 10. Pruritus Therapeutics Revenue by Company (2017-2022) & (US$ Million)

    Table 11. Pruritus Therapeutics Revenue Share by Company (2017-2022)

    Table 12. Ranking of Global Top Pruritus Therapeutics Players by Revenue (US$ Million) in 2021

    Table 13. Global Pruritus Therapeutics Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)

    Table 14. Global Pruritus Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pruritus Therapeutics as of 2021)

    Table 15. Global Pruritus Therapeutics Companies Headquarters

    Table 16. Global Pruritus Therapeutics Companies Product & Service

    Table 17. Date of International Companies Enter into Pruritus Therapeutics Market

    Table 18. Global Pruritus Therapeutics Mergers & Acquisitions, Expansion Plans

    Table 19. J&J Corporation Information

    Table 20. J&J Description and Business Overview

    Table 21. J&J Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 22. J&J Pruritus Therapeutics Product

    Table 23. J&J Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Product in 2021

    Table 24. J&J Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Application in 2021

    Table 25. J&J Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Geographic Area in 2021

    Table 26. J&J Recent Development

    Table 27. Abbott Corporation Information

    Table 28. Abbott Description and Business Overview

    Table 29. Abbott Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 30. Abbott Pruritus Therapeutics Product

    Table 31. Abbott Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Product in 2021

    Table 32. Abbott Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Application in 2021

    Table 33. Abbott Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Geographic Area in 2021

    Table 34. Abbott Recent Development

    Table 35. Amgen Corporation Information

    Table 36. Amgen Description and Business Overview

    Table 37. Amgen Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 38. Amgen Pruritus Therapeutics Product

    Table 39. Amgen Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Product in 2021

    Table 40. Amgen Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Application in 2021

    Table 41. Amgen Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Geographic Area in 2021

    Table 42. Amgen Recent Development

    Table 43. LEO Pharma Corporation Information

    Table 44. LEO Pharma Description and Business Overview

    Table 45. LEO Pharma Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 46. LEO Pharma Pruritus Therapeutics Product

    Table 47. LEO Pharma Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Product in 2021

    Table 48. LEO Pharma Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Application in 2021

    Table 49. LEO Pharma Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Geographic Area in 2021

    Table 50. LEO Pharma Recent Development

    Table 51. Novartis Corporation Information

    Table 52. Novartis Description and Business Overview

    Table 53. Novartis Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 54. Novartis Pruritus Therapeutics Product

    Table 55. Novartis Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Product in 2021

    Table 56. Novartis Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Application in 2021

    Table 57. Novartis Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Geographic Area in 2021

    Table 58. Novartis Recent Development

    Table 59. Bayer Corporation Information

    Table 60. Bayer Description and Business Overview

    Table 61. Bayer Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 62. Bayer Pruritus Therapeutics Product

    Table 63. Bayer Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Product in 2021

    Table 64. Bayer Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Application in 2021

    Table 65. Bayer Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Geographic Area in 2021

    Table 66. Pfizer Corporation Information

    Table 67. Pfizer Description and Business Overview

    Table 68. Pfizer Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 69. Pfizer Pruritus Therapeutics Product

    Table 70. Pfizer Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Product in 2021

    Table 71. Pfizer Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Application in 2021

    Table 72. Pfizer Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Geographic Area in 2021

    Table 73. UCB Pharma Corporation Information

    Table 74. UCB Pharma Description and Business Overview

    Table 75. UCB Pharma Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 76. UCB Pharma Pruritus Therapeutics Product

    Table 77. UCB Pharma Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Product in 2021

    Table 78. UCB Pharma Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Application in 2021

    Table 79. UCB Pharma Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Geographic Area in 2021

    Table 80. GlaxoSmithKline Corporation Information

    Table 81. GlaxoSmithKline Description and Business Overview

    Table 82. GlaxoSmithKline Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 83. GlaxoSmithKline Pruritus Therapeutics Product

    Table 84. GlaxoSmithKline Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Product in 2021

    Table 85. GlaxoSmithKline Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Application in 2021

    Table 86. GlaxoSmithKline Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Geographic Area in 2021

    Table 87. Galderma Corporation Information

    Table 88. Galderma Description and Business Overview

    Table 89. Galderma Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 90. Galderma Pruritus Therapeutics Product

    Table 91. Galderma Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Product in 2021

    Table 92. Galderma Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Application in 2021

    Table 93. Galderma Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Geographic Area in 2021

    Table 94. Huapont Corporation Information

    Table 95. Huapont Description and Business Overview

    Table 96. Huapont Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 97. Huapont Pruritus Therapeutics Product

    Table 98. Huapont Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Product in 2021

    Table 99. Huapont Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Application in 2021

    Table 100. Huapont Pruritus Therapeutics Revenue Proportion of Pruritus Therapeutics by Geographic Area in 2021

    Table 101. Global Pruritus Therapeutics Revenue by Type (2017-2022) & (US$ Million)

    Table 102. Global Pruritus Therapeutics Revenue by Application (2017-2022) & (US$ Million)

    Table 103. Global Pruritus Therapeutics Revenue Forecast by Application (2023-2028) & (US$ Million)

    Table 104. North America Pruritus Therapeutics Revenue by Country (2017-2022) & (US$ Million)

    Table 105. North America Pruritus Therapeutics Revenue by Country (2023-2028) & (US$ Million)

    Table 106. North America Pruritus Therapeutics Revenue by Type (2017-2022) & (US$ Million)

    Table 107. North America Pruritus Therapeutics Revenue by Application (2017-2022) & (US$ Million)

    Table 108. Asia-Pacific Pruritus Therapeutics Revenue by Region (2017-2028) & (US$ Million)

    Table 109. Asia-Pacific Pruritus Therapeutics Revenue by Region (2023-2028) & (US$ Million)

    Table 110. Asia-Pacific Pruritus Therapeutics Revenue by Type (2017-2022) & (US$ Million)

    Table 111. Asia-Pacific Pruritus Therapeutics Revenue by Application (2017-2022) & (US$ Million)

    Table 112. Europe Pruritus Therapeutics Revenue by Country (2017-2022) & (US$ Million)

    Table 113. Europe Pruritus Therapeutics Revenue by Country (2023-2028) & (US$ Million)

    Table 114. Europe Pruritus Therapeutics Revenue by Type (2017-2022) & (US$ Million)

    Table 115. Europe Pruritus Therapeutics Revenue by Application (2017-2022) & (US$ Million)

    Table 116. Latin America Pruritus Therapeutics Revenue by Country (2017-2022) & (US$ Million)

    Table 117. Latin America Pruritus Therapeutics Revenue by Country (2023-2028) & (US$ Million)

    Table 118. Latin America Pruritus Therapeutics Revenue by Type (2017-2022) & (US$ Million)

    Table 119. Latin America Pruritus Therapeutics Revenue by Application (2017-2022) & (US$ Million)

    Table 120. Middle East and Africa Pruritus Therapeutics Revenue by Country (2017-2022) & (US$ Million)

    Table 121. Middle East and Africa Pruritus Therapeutics Revenue by Country (2023-2028) & (US$ Million)

    Table 122. Middle East and Africa Pruritus Therapeutics Revenue by Type (2017-2022) & (US$ Million)

    Table 123. Middle East and Africa Pruritus Therapeutics Revenue by Application (2017-2022) & (US$ Million)

    Table 124. Pruritus Therapeutics Key Raw Materials, Industry Status and Trend

    Table 125. Pruritus Therapeutics Key Raw Materials and Upstream Suppliers

    Table 126. Pruritus Therapeutics Clients Status and Trend

    Table 127. Pruritus Therapeutics Typical Clients

    Table 128. Pruritus Therapeutics Distributors

    Table 129. Pruritus Therapeutics Market Trends

    Table 130. Pruritus Therapeutics Market Drivers

    Table 131. Pruritus Therapeutics Market Challenges

    Table 132. Pruritus Therapeutics Market Restraints

    Table 133. Research Programs/Design for This Report

    Table 134. Key Data Information from Secondary Sources

    Table 135. Key Data Information from Primary Sources

List of Figures

    Figure 1. Pruritus Therapeutics Product Picture

    Figure 2. Global Pruritus Therapeutics Revenue Market Share by Type in 2021 & 2028

    Figure 3. Antihistamines Product Picture

    Figure 4. Corticosteroids Product Picture

    Figure 5. Calcineurin Inhibitors Product Picture

    Figure 6. Others Product Picture

    Figure 7. Global Pruritus Therapeutics Revenue Market Share by Application in 2021 & 2028

    Figure 8. External Use

    Figure 9. Oral

    Figure 10. Injection

    Figure 11. Pruritus Therapeutics Report Years Considered

    Figure 12. Global Pruritus Therapeutics Revenue, (US$ Million), 2017 VS 2021 VS 2028

    Figure 13. Global Pruritus Therapeutics Market Size 2017-2028 (US$ Million)

    Figure 14. Global Pruritus Therapeutics Market Size Market Share by Region: 2022 Versus 2028

    Figure 15. Global Pruritus Therapeutics Revenue Market Share by Region (2017-2028)

    Figure 16. Pruritus Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021

    Figure 17. Global Pruritus Therapeutics Revenue Market Share Forecast by Type (2017-2028)

    Figure 18. Global Pruritus Therapeutics Revenue Market Share Forecast by Application (2017-2028)

    Figure 19. North America Pruritus Therapeutics Revenue 2017-2028 (US$ Million)

    Figure 20. North America Pruritus Therapeutics Revenue Market Share by Type (2017-2022)

    Figure 21. North America Pruritus Therapeutics Revenue Market Share by Application (2017-2022)

    Figure 22. Asia-Pacific Pruritus Therapeutics Revenue 2017-2028 (US$ Million)

    Figure 23. Asia-Pacific Pruritus Therapeutics Revenue Market Share by Region (2017-2028)

    Figure 24. Asia-Pacific Pruritus Therapeutics Revenue Market Share by Type (2017-2022)

    Figure 25. Asia-Pacific Pruritus Therapeutics Revenue Market Share by Application (2017-2022)

    Figure 26. Europe Pruritus Therapeutics Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 27. Europe Pruritus Therapeutics Revenue Market Share by Country (2017-2028)

    Figure 28. Europe Pruritus Therapeutics Revenue Market Share by Type (2017-2022)

    Figure 29. Europe Pruritus Therapeutics Revenue Market Share by Application (2017-2022)

    Figure 30. Latin America Pruritus Therapeutics Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 31. Latin America Pruritus Therapeutics Revenue Market Share by Country (2017-2022)

    Figure 32. Latin America Pruritus Therapeutics Revenue Market Share by Type (2017-2022)

    Figure 33. Latin America Pruritus Therapeutics Revenue Market Share by Application (2017-2022)

    Figure 34. Middle East and Africa Pruritus Therapeutics Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 35. Middle East and Africa Pruritus Therapeutics Revenue Market Share by Country (2017-2028)

    Figure 36. Middle East and Africa Pruritus Therapeutics Revenue Market Share by Type (2017-2022)

    Figure 37. Middle East and Africa Pruritus Therapeutics Revenue Market Share by Application (2017-2022)

    Figure 38. Pruritus Therapeutics Supply Chain (Upstream and Downstream Market)

    Figure 39. Global Production Market Share of Pruritus Therapeutics Raw Materials by Region in 2021

    Figure 40. Pruritus Therapeutics Distribution Channels

    Figure 41. Global Pruritus Therapeutics Percentage 2017-2028: Indirect Sales VS Direct Sales

    Figure 42. Global Pruritus Therapeutics Percentage 2017-2028: Online Sales VS Offline Sales

    Figure 43. Bottom-up and Top-down Approaches for This Report

    Figure 44. Data Triangulation

    Figure 45. Key Executives Interviewed